InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | 2026-05-11 | Azoulay Salomon | Chief Medical Officer | Sale | 70.0K | $38.36 | $2.69M | 14.8K | View ↗ | |
| 2026-05-06 | 2026-05-08 | Azoulay Salomon | Chief Medical Officer | Sale | 231 | $29.54 | $7K | 14.8K | View ↗ | |
| 2026-05-06 | 2026-05-08 | Hawryluk P. Kent | Director & President & CEO | Sale | 607 | $29.54 | $18K | 727.7K | View ↗ | |
| 2026-03-13 | 2026-03-16 | Hawryluk P. Kent | Director & President & CEO | Purchase | 18.5K | $28.41 | $526K | 486.8K | View ↗ |
No annual data found.
Insider Stock Buying Reaches US$1.06m On MBX Biosciences
MBX Biosciences, Inc. (MBX) Discusses Novel Approaches and Clinical Progress in Obesity Therapeutics Portfolio - Slideshow
MBX Biosciences, Inc. (MBX) Discusses Novel Approaches and Clinical Progress in Obesity Therapeutics Portfolio Transcript
MBX Biosciences Obesity Day Spotlights Monthly GLP-1 Hope and Pipeline Push